comparemela.com
Home
Live Updates
JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain : comparemela.com
JanOne Earns US Patent for the Use of its Novel Formulation of Low-Dose Naltrexone, Jan123, to Treat Chronic Pain
/PRNewswire/ -- JanOne (Nasdaq: JAN), the visionary biotech company dedicated to discovering non-addictive treatments for pain, as well as causes of pain, has...
Related Keywords
Amol Soin ,
Tony Isaac ,
Tony Giordano ,
Janone Inc ,
Exchange Commission ,
Us Patent Office ,
Broad Patent Coverage ,
Major Milestone ,
Commercial Success ,
Chief Scientific ,
Private Securities Litigation Reform Act ,
comparemela.com © 2020. All Rights Reserved.